Volitionrx annual operating margin
2012
2014
2019
2020
2021
2022
2023
2024
2025
Volitionrx's operating margin was −1,258.47% for fiscal 2025.
View full Volitionrx company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,258.47% | +932.43 pp |
| 2024 | 2024-12-31 | −2,190.90% | +2450.87 pp |
| 2023 | 2023-12-31 | −4,641.76% | +5730.59 pp |
| 2022 | 2022-12-31 | −10,372.36% | +21096.60 pp |
| 2021 | 2021-12-31 | −31,468.96% | +126707.28 pp |
| 2020 | 2020-12-31 | −158,176.25% | −64336.03 pp |
| 2019 | 2019-12-31 | −93,840.22% | −53581.85 pp |
| 2014 | 2014-12-31 | −40,258.37% | −32830.32 pp |
| 2012 | 2012-12-31 | −7,428.05% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,042.50% | +506.06 pp |
| Q1 2026 | 2026-03-31 | −542.99% | +1698.11 pp |
| Q4 2025 | 2025-12-31 | −1,077.78% | +1938.72 pp |
| Q3 2025 | 2025-09-30 | −813.20% | +423.57 pp |
| Q2 2025 | 2025-06-30 | −1,548.56% | +217.60 pp |
| Q1 2025 | 2025-03-31 | −2,241.09% | +2646.83 pp |
| Q4 2024 | 2024-12-31 | −3,016.50% | +566.10 pp |
| Q3 2024 | 2024-09-30 | −1,236.76% | +4000.82 pp |
| Q2 2024 | 2024-06-30 | −1,766.16% | +2648.35 pp |
| Q1 2024 | 2024-03-31 | −4,887.93% | +1149.82 pp |
| Q4 2023 | 2023-12-31 | −3,582.60% | +3108.85 pp |
| Q3 2023 | 2023-09-30 | −5,237.58% | +19195.25 pp |
| Q2 2023 | 2023-06-30 | −4,414.51% | +15960.50 pp |
| Q1 2023 | 2023-03-31 | −6,037.75% | +684.00 pp |
| Q4 2022 | 2022-12-31 | −6,691.45% | +55001.11 pp |
| Q3 2022 | 2022-09-30 | −24,432.83% | +5243.00 pp |
| Q2 2022 | 2022-06-30 | −20,375.01% | +3435.24 pp |
| Q1 2022 | 2022-03-31 | −6,721.75% | +17113.39 pp |
| Q4 2021 | 2021-12-31 | −61,692.56% | +17789.45 pp |
| Q3 2021 | 2021-09-30 | −29,675.83% | +753701.56 pp |
| Q2 2021 | 2021-06-30 | −23,810.25% | +76543.58 pp |
| Q1 2021 | 2021-03-31 | −23,835.14% | +1055557.88 pp |
| Q4 2020 | 2020-12-31 | −79,482.01% | −55054.38 pp |
| Q3 2020 | 2020-09-30 | −783,377.39% | −771450.56 pp |
| Q2 2020 | 2020-06-30 | −100,353.83% | −97191.28 pp |
| Q1 2020 | 2020-03-31 | −1,079,393.01% | −1071436.53 pp |
| Q3 2019 | 2019-09-30 | −24,427.63% | −19311.88 pp |
| Q3 2014 | 2014-09-30 | −11,926.83% | — |
| Q3 2012 | 2012-09-30 | −3,162.55% | — |
| Q2 2012 | 2012-06-30 | −7,956.49% | — |
| Q1 2012 | 2012-03-31 | −5,115.75% | — |
Over the last five reported fiscal years, Volitionrx's operating margin increased from −158,176.25% to −1,258.47%, a change of +156917.78 percentage points. The latest reported quarter, Q2 2026, shows −1,042.50%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Volitionrx filings at SEC.gov ↗